Rohto Pharmaceutical Co.Ltd. (RPHCF) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Rohto Pharmaceutical Co.L...

PNK: RPHCF · Real-Time Price · USD
20.09
-6.54 (-24.56%)
At close: Jan 24, 2025, 9:00 PM

Rohto Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Cash & Equivalents
89.21B 584.78M 582.48M 472.9M
Short-Term Investments
n/a 17.01M 15.49M 6.42M
Long-Term Investments
n/a 253.19M 231.1M 267.76M
Other Long-Term Assets
49.72B -9.45B -9.42B -7.81B
Receivables
n/a n/a n/a n/a
Inventory
46.66B 309.07M 275.42M 252.71M
Other Current Assets
78.89B 69.23B 57.99B 52.18B
Total Current Assets
214.76B 1.43B 1.35B 1.2B
Property-Plant & Equipment
68.61B 498.15M 516.22M 450.59M
Goodwill & Intangibles
9.22B 9.56B 9.54B 7.89B
Total Long-Term Assets
131.41B 898.96M 908.33M 842.33M
Total Assets
346.18B 2.33B 2.26B 2.05B
Account Payables
16.99B 16.02B 13.66B 9.6B
Deferred Revenue
n/a 38M 25.11M 44.78M
Short-Term Debt
5.3B 4.18B 8.03B 2.31B
Other Current Liabilities
58.15B -25.83B -24.29B 38.42B
Total Current Liabilities
87.09B 603.38M 587.27M 511.05M
Long-Term Debt
5.19B 7.52B 13.35B 5.79B
Other Long-Term Liabilities
2.68B -8.58B -14.73B -6.67B
Total Long-Term Liabilities
12.05B 108.64M 159.3M 118.23M
Total Liabilities
99.14B 712.02M 746.57M 629.28M
Total Debt
10.49B 102.46M 178.44M 76.81M
Common Stock
6.5B 48.96M 53.43M 58.86M
Retained Earnings
209.4B 1.39B 1.33B 1.32B
Comprehensive Income
n/a 140.79M 71.76M 28.66M
Shareholders Equity
246.32B 1.58B 1.47B 1.41B
Total Investments
44.34B 270.2M 246.6M 274.17M